Covaxin the inactivated vaccine reaches India cities, though final trial reports are awaited... Jan 14
Bharat Biotech has announced successful recruitment of 13,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical ... Dec 22
The vaccine was co-invented by the University of Oxford and its spin-out company Vaccitech... Dec 12
The Phase III trials will involve 26,000 volunteers across India, conducted in partnership with ICMR... Nov 17
Basilea announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ramucirumab in the ongoing FIDES-03 study with derazantinib in gastric ... Oct 28
The International Day of Sign Languages is a unique opportunity to support and protect the linguistic identity and cultural diversity of all deaf people and ... Sep 23
Yogi Adityanath said testing is only way to fight Corona... Sep 01
The vaccine was found to be safe, immunogenic and well tolerated in the pre-clinical toxicity studies, it also able to elicit high level of ... Aug 05
India Coronavirus update ,August 5... Aug 05
Bharat Biotech's Covaxin human trial starts across India... Jul 24
Delhi sero prevalence report says most of the affected are asymptotic... Jul 21
Human dosing of the vaccine marks a key milestone since the launching of the accelerated vaccine development programme for COVID-19 in February 2020.... Jul 15
Bharat Biotech has successfully developed COVAXIN™, India’s 1st vaccine candidate for COVID-19.... Jun 30
Corononavirus Bio Banks will help in research as well as vaccine development... May 30
Dr Harsh Vadhan dedicated Cobas 800 testing machines to the nation... May 15
Halodine Nasal and Oral Antiseptics Show Rapid Antiviral Activity Against SARS-CoV-2 (COVID-19) ... May 14
The researchers would endeavour to come out with products that are biocompatible, low cost and scalable and have set out with a timeline of six ... Apr 23
CSIR-IMTECH takes up sample testing for Covid-19 ... Apr 04
-Advertisements-
Monday, April 29, 2024
.jpg)
